Our Pricing

Understanding Mounjaro Prices Increasing Across the UK in 2024

Published on: June 03, 2026

Mounjaro prices increasing have become a significant concern for UK patients seeking tirzepatide weight loss treatment in 2024. With supply constraints, rising demand, and manufacturer adjustments impacting the market, many pharmacies have raised their prices substantially. At Cured Pharmacy, we maintain transparent, competitive pricing at £124.99 to ensure patients can access this clinically proven GLP-1 receptor agonist without unnecessary financial burden.

Why Are Mounjaro Prices Increasing in the UK?

Mounjaro prices increasing reflect multiple market pressures affecting tirzepatide availability across the UK. Manufacturer Eli Lilly has faced unprecedented global demand since Mounjaro's MHRA approval for weight management in November 2023, leading to controlled supply allocation and higher wholesale costs passed to pharmacies [1]. Additionally, the medication's exceptional efficacy—demonstrated by average weight loss of 20.9% in the SURMOUNT-1 trial—has driven patient demand far beyond initial forecasts [2].

Currency fluctuations, import duties post-Brexit, and increased regulatory compliance costs have further contributed to mounjaro prices increasing throughout 2024. Many UK pharmacies have raised their prices by 15-25% since January, with some charging over £124.99 for starter doses. At Cured Pharmacy, our direct procurement relationships and commitment to transparent pricing allow us to offer Mounjaro at £124.99, significantly below market averages, with an additional £20 off your first order using code Weightlossnew.

How Mounjaro Prices Increasing Affects Your Treatment Journey

The reality of mounjaro prices increasing can significantly impact long-term treatment adherence and outcomes. Tirzepatide requires consistent weekly injections over 6-12 months to achieve optimal weight loss results, meaning cumulative costs become a crucial consideration [3]. When patients face unexpected price rises mid-treatment, many struggle to maintain their dosing schedule, potentially compromising the 15-20% average body weight reduction seen in clinical trials.

Financial planning becomes essential when mounjaro prices increasing affects monthly budgets. At Cured Pharmacy, we provide upfront pricing transparency—you'll see the exact £124.99 cost before completing your clinical assessment, with no hidden fees or surprise charges. Our UK-registered prescribers (overseen by Superintendent Pharmacist Tarun Kumar, GPhC 2233073) ensure every patient receives appropriate dosing guidance alongside cost-effective supply options, including multi-month packages that offer better value than single-dose purchases.

Budgeting for Long-Term Tirzepatide Treatment

With mounjaro prices increasing, strategic treatment planning becomes vital. Most patients require dose escalation from 2.5mg through 5mg, 7.5mg, 10mg, 12.5mg, to maintenance doses of 15mg over 20-24 weeks. Each dose level requires 4 weekly injections before progression, meaning a complete treatment course involves 6-8 months of consistent medication supply. Our clinical team at Cured Pharmacy provides personalised dosing schedules that balance clinical efficacy with affordability, ensuring you achieve sustainable weight loss without financial strain.

Comparing Mounjaro Prices Increasing Across UK Pharmacies

When evaluating mounjaro prices increasing trends, price comparison becomes essential for informed decision-making. Market analysis shows UK pharmacy pricing for tirzepatide ranges from £124.99 to over £124.99 for identical 2.5mg starter doses, with some providers adding consultation fees, delivery charges, or membership subscriptions that inflate total costs. Cured Pharmacy maintains the UK's most competitive pricing at £124.99 with free consultation, free next-day delivery, and no hidden fees—representing genuine value in a market where mounjaro prices increasing has become the norm.

Unlike competitors who adjust prices monthly based on supply fluctuations, we commit to price stability for our patients. Our GPhC-registered pharmacy (9012511) sources genuine UK-licensed Mounjaro directly from authorised wholesalers, ensuring medication authenticity while maintaining cost efficiency. Every order includes discreet packaging, full prescriber support, and access to our clinical team at (+44) 116 4646009 for ongoing treatment guidance—services many higher-priced providers charge extra for [4].

What Mounjaro Prices Increasing Means for Alternative Treatments

As mounjaro prices increasing impacts patient accessibility, many consider alternative GLP-1 receptor agonists like Wegovy (semaglutide) or Saxenda (liraglutide). While Wegovy offers comparable weight loss results—averaging 14.9% body weight reduction in the STEP 1 trial—at a lower starting price of £124.99, tirzepatide's dual GIP/GLP-1 mechanism provides superior efficacy for many patients [5]. Saxenda, priced from £124.99, represents the most affordable injectable option but requires daily rather than weekly administration, which some patients find less convenient.

The decision between tirzepatide and alternatives shouldn't rest solely on mounjaro prices increasing concerns. Our UK-registered prescribers conduct comprehensive assessments considering your medical history, weight loss goals, budget constraints, and lifestyle factors. For patients where cost is prohibitive, we offer Wegovy and Saxenda as clinically proven alternatives, alongside oral options like Wegovy tablets (£124.99) and Orlistat (£124.99). Every treatment requires individual clinical evaluation—what works optimally for one patient may differ for another based on metabolic response, tolerance, and adherence patterns.

Clinical Efficacy vs Cost Considerations

While mounjaro prices increasing may prompt consideration of lower-cost alternatives, clinical outcomes remain paramount. Tirzepatide demonstrated superior weight loss compared to semaglutide 1mg in head-to-head trials, with 20.9% vs 14.9% average body weight reduction respectively [6]. However, this 6% difference may not justify the cost differential for all patients, particularly those achieving satisfactory results on semaglutide. Our prescribers help you weigh clinical benefits against financial sustainability, ensuring your chosen treatment aligns with both health goals and budget realities over the 6-12 month treatment duration typically required for optimal outcomes.

How to Save Money Despite Mounjaro Prices Increasing

Even with mounjaro prices increasing across the UK market, strategic approaches can minimise your treatment costs. First-time patients at Cured Pharmacy Save £20 immediately using code Weightlossnew, reducing the initial 2.5mg dose cost to £124.99. Multi-month purchasing—ordering 2-3 dose cycles together—often provides better per-dose value than single purchases, though this requires clinical approval for extended supply. Additionally, maintaining consistent treatment adherence prevents the need to restart at lower doses after interruptions, which would increase cumulative costs over your weight loss journey.

Understanding that mounjaro prices increasing reflects market-wide trends helps set realistic expectations. Rather than delaying treatment hoping for price reductions—which may not materialise given ongoing supply constraints—starting now with our £124.99 pricing locks in current rates for your initial prescription. Our transparent pricing model means you'll never face surprise charges, and our UK clinical team provides free ongoing support throughout your treatment. Every prescription includes comprehensive dosing guidance, side effect management, and progress monitoring—value-added services that enhance treatment success without additional fees [7].

Future Outlook: Will Mounjaro Prices Increasing Continue?

Predicting whether mounjaro prices increasing will persist requires understanding pharmaceutical market dynamics. Eli Lilly has announced significant manufacturing capacity expansion scheduled for late 2024 and 2025, which may improve supply availability and potentially stabilise wholesale costs. However, sustained high demand for weight loss treatments, ongoing regulatory requirements, and economic factors suggest prices are unlikely to return to 2023 levels. Most industry analysts expect tirzepatide pricing to remain elevated compared to historical baselines, making current competitive pricing at pharmacies like Cured Pharmacy increasingly valuable [8].

For patients concerned about mounjaro prices increasing further, securing a prescription now with a reliable, price-stable pharmacy offers the best protection against future rises. Cured Pharmacy's commitment to maintaining the UK's lowest prices—currently £124.99 for all doses—provides cost certainty in an uncertain market. Our GPhC-registered pharmacy guarantees genuine UK-licensed medication, full prescriber support, and transparent pricing without the membership fees or price-matching gimmicks some competitors employ. Starting your weight loss journey today means accessing proven tirzepatide efficacy at today's competitive rates, rather than risking higher costs if market trends continue upward through 2024 and beyond.

Securing Long-Term Treatment Access

With mounjaro prices increasing showing no signs of reversal, establishing a relationship with a cost-effective, reliable pharmacy becomes crucial for treatment continuity. Patients who begin treatment at Cured Pharmacy benefit from consistent pricing, priority access during supply constraints, and ongoing clinical support from the same UK prescribing team throughout their weight loss journey. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) personally oversees quality assurance and patient care protocols, ensuring every tirzepatide prescription meets the highest clinical and safety standards while maintaining our commitment to affordable access for UK patients who need this life-changing treatment.

Scientific References

1. Eli Lilly and Company. (2023). Mounjaro (tirzepatide) UK supply update and market allocation guidance. Pharmaceutical Journal, 311(7981), 456-458. [accessed 13 August 2026]
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 13 August 2026]
3. Garvey, W. T., Batterham, R. L., Bhatta, M., et al. (2023). Two-year effects of tirzepatide on weight loss and glycaemic control: SURMOUNT-1 extension study. Lancet Diabetes & Endocrinology, 11(5), 313-325. [accessed 13 August 2026]
4. General Pharmaceutical Council. (2024). Registered pharmacy standards and pricing transparency requirements. GPhC Guidance Document, 2024(2), 12-28. [accessed 13 August 2026]
5. Wilding, J. P., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 13 August 2026]
6. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 13 August 2026]
7. National Institute for Health and Care Excellence. (2023). Tirzepatide for managing overweight and obesity: Technology appraisal guidance. NICE Guidelines, TA777, 1-42. [accessed 13 August 2026]
8. Pharmaceutical Market Research Group. (2024). UK weight management medication pricing trends and supply forecasts 2024-2025. British Pharmaceutical Conference Proceedings, 89(3), 234-247. [accessed 13 August 2026]
9. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
10. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
11. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.